Overview

Gender

male

Branden Ryu is the founder, the chief executive officer, and the chairman of BIORCHESTRA.

Branden earned his Ph.D. degree from the Graduate school of medicine at the University of Tokyo and completed the Harvard MIT health science and technology internship program at MGH. Also, he has experience as a researcher at Harvard medical school.



After his research career, he found BIORCHESTRA to focus on developing RNA-based therapeutics in 2016.
He has discovered the novel RNA biomarker and invented the novel ASO modality to treat neurodegenerative diseases. Under his leadership, BIORCHESTRA has expanded the new RNA modalities to cure neurological disorders including genetic rare diseases. Based on these scientific results, he has filed more than 70 patent applications since 2017.